INTERACTION OF C-TERMINAL SEQUENCES OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE WITH TEMPLATE PRIMER

被引:0
|
作者
DEVICO, AL
COPELAND, TD
OROSZLAN, S
GALLO, RC
SARNGADHARAN, MG
机构
[1] NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MOLEC VIROL & CARCINOGENESIS LAB,FREDERICK,MD 21702
[2] NCI,TUMOR CELL BIOL LAB,BETHESDA,MD 20892
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have raised a rabbit monospecific antibody (designated C2003) against a synthetic peptide (CTP66) derived from a conserved sequence in the C-terminal portion of the p66 component of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) (DeVico, A. L., Copeland, T. D., Veronese, F. D., Oroszlan, S., Gallo, R. C., and Sarngadharan, M. G. (1989) AIDS Res. Hum. Retroviruses 5, 51-60). This antibody directly inhibits the polymerase activity of HIV-1 RT and of RTs from a variety of retroviruses. HIV-1 RT is protected from this inhibition by preincubation of the enzyme with template primer prior to treatment with the antibody. Such protection is abrogated when the pretreatment is conducted under conditions of high ionic strength. Kinetic studies showed that the antibody-mediated inhibition is competitive with respect to template primer concentration. These results indicate that C2003 antibody acts to interfere with the template binding function of the enzyme and further indicates that conserved residues recognized by the antibody may be directly involved in this function.
引用
收藏
页码:6774 / 6779
页数:6
相关论文
共 50 条
  • [1] HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE - EFFECT OF PRIMER LENGTH ON TEMPLATE-PRIMER BINDING
    REARDON, JE
    FURFINE, ES
    CHENG, N
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1991, 266 (21) : 14128 - 14134
  • [2] IDENTIFICATION OF THE PRIMER BINDING DOMAIN IN HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    BASU, A
    AHLUWALIA, KK
    BASU, S
    MODAK, MJ
    BIOCHEMISTRY, 1992, 31 (02) : 616 - 623
  • [3] MISINCORPORATION AND MISPAIRED PRIMER EXTENSION BY HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    ZINNEN, S
    HSIEH, JC
    MODRICH, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (39) : 24195 - 24202
  • [4] HYDROXYL RADICAL FOOTPRINT ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE TEMPLATE.PRIMER COMPLEXES
    METZGER, W
    HERMANN, T
    SCHATZ, O
    LEGRICE, SFJ
    HEUMANN, H
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) : 5909 - 5913
  • [5] RIBAVIRIN IS AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    FERNANDEZLARSSON, R
    PATTERSON, JL
    MOLECULAR PHARMACOLOGY, 1990, 38 (06) : 766 - 770
  • [6] HUMAN-IMMUNODEFICIENCY-VIRUS - PLAYING CHESS WITH REVERSE-TRANSCRIPTASE
    RICHMAN, DD
    NATURE, 1993, 361 (6413) : 588 - 589
  • [7] INTERACTION OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH DNA
    BAKHANASHVILI, M
    HIZI, A
    BIOCHEMISTRY, 1994, 33 (40) : 12222 - 12228
  • [8] INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 REVERSE-TRANSCRIPTASE ACTIVITY BY RUBROMYCINS - COMPETITIVE INTERACTION AT THE TEMPLATE - PRIMER SITE
    GOLDMAN, ME
    SALITURO, GS
    BOWEN, JA
    WILLIAMSON, JM
    ZINK, DL
    SCHLEIF, WA
    EMINI, EA
    MOLECULAR PHARMACOLOGY, 1990, 38 (01) : 20 - 25
  • [9] DOMAIN-STRUCTURE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    LEDERER, H
    SCHATZ, O
    MAY, R
    CRESPI, H
    DARLIX, JL
    LEGRICE, SFJ
    HEUMANN, H
    EMBO JOURNAL, 1992, 11 (03): : 1131 - 1139
  • [10] AN EXPANDED MODEL OF REPLICATING HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
    WOHRL, BM
    TANTILLO, C
    ARNOLD, E
    LEGRICE, SFJ
    BIOCHEMISTRY, 1995, 34 (16) : 5343 - 5350